ArticlePloS one2015

Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model.

Cornelia Braicu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.